The new Cooltech Define delivers reliable and price-sensitive cryoadipolysis technology, with extremely low consumable cost, offering clinics easy entry to this market segment, which is in long-term growth.
KEY ADVANTAGES
- Low-cost consumables
- 360° cooling plates
- 4 applicators working in unison
- 9 applicator shapes including the double handpiece with cooling surface of 318.59cm2
- 9 matching templates
- 1 massager handpiece
- New gel pad to protect skin up to -50°C
Listed on TGA / ATRG # 367730
Cocoon Medical
Since its launch in Barcelona in 2010, and subsequent acquisition by Sinclair Pharma in 2021, Cocoon Medical has experienced rapid growth, thanks to its demonstrated ability to to develop and manufacture innovative and reliable aesthetic devices that create demand for progressive practices, particularly in the field of non-surgical body sculpting.
Cocoon Medical offers an innovative portfolio of non-invasive lasers and cryoadipolysis (freeze-induced fat cell apoptosis) devices for both clinics and medspas. All products have been developed by Cocoon’s inhouse R&D team and are produced at Cocoon’s own facility in Sofia, Bulgaria. Cocoon has direct commercial operations in Europe, Latin America, Hong Kong and the US, and in addition manages a network of over 60 distributors.
Cocoon’s products combine outstanding technology, build quality and user flexibility with competitive pricing and profitability to generate an industry-leading value proposition.
For more information contact Advanced Cosmeceuticals:
P 1800 242 011
E cs@advancedcosmeceuticals.com.au
www.cocoonmedicalaustralia.com.au